Search images on Google      Product Monograph

Active Ingredients:

• bevacizumab, 25 MG/ML

DIN: 02470748

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: 100 MG/4 ML. SINGLE-USE VIAL.

Schedule: Prescription

Company: AMGEN CANADA INC

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01F - (ATC, WHO)
• L01FG - (ATC, WHO)
• L01FG01 - BEVACIZUMAB (WHO)

 

External Links for Mvasi:

Search on Google

• Mvasi side effects
• Mvasi dosage
• bevacizumab side effects
• bevacizumab dosage